- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07944079
Acupuncture Delivery In The Clinical Decision Unit (CDU) For The Management Of Pain, Nausea, And Other Symptoms
The overall goal of this research is to improve the management of distressing symptoms, specifically nausea and pain, in cancer patients within the acute care setting of the CDU at MD Anderson.
Studieöversikt
Detaljerad beskrivning
Primary Objectives and Endpoints:
Determine the feasibility of an operational protocol of providing acupuncture treatment for nausea and/or pain in the CDU at MD Anderson Cancer Center. Feasibility will be assessed by the proportion of eligible patients who consent to and receive at least one acupuncture treatment. Successful feasibility will be defined as at least 50% of the eligible patients approached consenting and receiving at least one acupuncture session.
Secondary Objectives and Endpoints:
- Examine changes in pain and nausea reported in cancer patients after a single session of acupuncture in the CDU. Preliminary efficacy will be evaluated by having patients complete the ESAS symptom severity before and after each acupuncture session.
- Examine changes in other symptoms assessed on the ESAS after a single session of acupuncture in the CDU. Individual items will be explored as well as global (all symptoms), physical (drowsiness, nausea, pain, shortness of breath, poor appetite, fatigue), and psychological distress (anxiety and depression) subscales.
- Explore the safety profile of providing acupuncture in the CDU. Data will be collected to systematically document and grade any adverse events related to the acupuncture treatment according to the Common Terminology Criteria for Adverse Events (CTCAE) v6.0.
- Explore the patient experience with acupuncture in the CDU. Patients will be asked about their satisfaction with acupuncture, whether they believe it was helpful to reduce their symptoms, if they would use the service again, and if they would recommend acupuncture to others in the CDU. An additional open-ended question will allow patients to make recommendations for future program or service offerings. Satisfaction will be administered to all study participants after each treatment.
- Explore the CDU staff experience with acupuncture in the CDU. The primary clinician assigned to the patient will be asked about their satisfaction with the use of acupuncture for the patient. They will be asked about the logistics of delivering acupuncture and if they perceive any benefit for the patient from before to after in terms of pain, nausea, or anxiety.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Maxine De La Cruz, MD
- Telefonnummer: 713-563-4419
- E-post: mgde@mdanderson.org
Studieorter
-
-
Texas
-
Houston, Texas, Förenta staterna, 77030
- UT MD Anderson
-
Kontakt:
- Maxine De La Cruz, MD
- Telefonnummer: 713-563-4419
- E-post: mgde@mdanderson.org
-
Huvudutredare:
- Maxine De La Cruz, MD
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Adult patients (aged ≥18 years)
- Presenting with a primary complaint of nausea and/or pain
- ESAS nausea and/or pain score of at least 2
- Admitted to the CDU for observation and management of nausea and/or pain.
Exclusion Criteria:
An individual who meets any of the following criteria will be excluded from participation in this study:
- History of a bleeding disorder
- Coagulation profile with an INR > 2.0 and/or PTT > 90 seconds
- Initiation of anticoagulation for venous thrombosis within the last 24 hours or not yet at a therapeutic dose
- Evidence of bowel obstruction on imaging
- Platelet count < 25,000/uL
- Absolute Neutrophil Count (ANC) < 1.0 K/uL
- Delirium or cognitive impairment in the opinion of the primary CDU physician that limits the ability to follow instructions or provide informed consent.
- Pregnant patients for whom the treating physician or acupuncturist determines acupuncture is not clinically appropriate.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Treatment with Acupuncture
Participants to recruit from are those participants who are admitted into the CDU at UT MD Anderson. |
Treatment will be administered at the participant's bedside in CDU. Needles will remain in place for 20-25 minutes with each treatment. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Safety and Adverse Events (AEs)
Tidsram: Through study completion; an average of 1 year
|
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 6.0 |
Through study completion; an average of 1 year
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Maxine De La Cruz, MD, UT MD Anderson
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 2026-0644
- NCI-2026-08619 (Annan identifierare: NCI-CTRP Clinical Trials Registry)
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .